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Perinatal strokeThe pathogenesis of disease progression in drug-refractory epilepsy is poorly understood.We report the case of a
young woman with a four-year history of epilepsy that progressed rapidly as evidenced by the development of
progressive focal cortical atrophy. She underwent biopsy that showed perinatal ischemia and a prominent
inﬂammatory response, including T-cell inﬁltration and microglial activation. There was no consensus reached
on the ﬁnal diagnosis although the hypothesis of dual pathology (adult variant of Rasmussen's encephalitis
and perinatal stroke) was considered. The possible role of inﬂammation in the progression of epilepsy caused
by a “static” lesion (perinatal stroke) is discussed.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Disease progression in drug-refractory epilepsy has been evaluated
in multiple studies using serial cognitive assessments [1] and MRI
volumetric analysis [2,3]. Although the pathogenesis of such changes
is not fully understood, experimental [4] and clinical studies [5,6]
suggest that they may be related to recurrent seizures. The duration of
progression is often up to a decade before being evident as cortical atro-
phy on serial MRI [7]. Management is challenging as the underlying
etiopathogenesis is unclear and the outcome is often suboptimal. We
report a case of a young woman with focal epilepsy that progressed
rapidly within four years of onset.
2. Case report
A 28-year-old, right-handed woman with a four-year history of
medication-resistant epilepsy was referred for further management.
Seizure semiology included auras that she described as “gradual loss
of hearing, feels as if distant” followed by loss of consciousness, general-
ized tonic–clonic convulsions, and postictal confusion and lethargy.
There was no diurnal preference for these seizures, and they were not
speciﬁcally related to her sleep–wake cycle. Initially, the seizures occur-
ring once a month steadily increased in frequency to 2–3/month.
Her birth history was unremarkable, and her development was
normal. She graduated from law school and was working at a companyospital, Wang ACC 739 L, Fruit
11; fax: +1 617 726 9250.
. This is an open access article underas a manager. Neurological examination was unremarkable. Neuropsy-
chological testing displayed strengths in the areas of her fund of knowl-
edge, verbal expression and ﬂuency, information-processing speed, and
executive cognitive control. Mild relative weaknesses were seen in
visuospatial and perceptual skills, visual learning, left hand speed and
coordination, and in concentration and working memory. Overall, the
neuropsychological testing revealed a mildly lateralized cognitive
proﬁle that was suggestive of nondominant frontal lobe dysfunction.
Magnetic resonance imaging of the brain performed at the time of ini-
tial presentation showed encephalomalacia affecting the anterior and the
inferior portion of the right frontal lobe, with involvement of the anterior
aspect of the right middle and perifrontal gyri as well as the right
orbitofrontal gyrus. There was another discrete noncontiguous focus of
encephalomalacia involving the posterior right frontal operculum. The
hippocampiwere symmetric andnormal in size and signal intensity. Sub-
sequent serial brain MRIs performed yearly showed progressive atrophy
in the right anterior quadrant that was conﬁrmed by quantitative volu-
metric analysis (Figs. 1 and 2). Fluorine-18 ﬂuorodeoxyglucose
(18FDG) PET scan showed marked cortical hypometabolism in the
right hemisphere, most pronounced proximal to the areas of
encephalomalacia in the anterior right frontal lobe and in the right fron-
tal operculum.
Interictal EEG recorded from scalp showed frequent intermittent
focal delta slowing over the right anterior quadrant and abundant
epileptiform sharp waves over the right frontotemporal region.
Five electroclinical seizures recorded from the scalp began with an ex-
periential followed by head version to left, left arm tonic extension
and right arm ﬂexion, and then tonic–clonic activity. The electrographicthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. (a) BrainMRI axial FLAIR and (b) T2-weighted sequence showing encephalomalacia
in the anterior right frontal lobe and another discrete noncontiguous focus of
encephalomalacia involving the posterior right frontal operculum.
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over the right frontopolar (Fp2) or the right superior frontal region (F4).
Given her increased seizure frequency and resultant disability,
epilepsy surgery was considered. In the epilepsy surgical conference,
the discussion was focused around two key aspects: a) possible etiology
of focal epilepsy and b) surgical planning. Many members of the group
felt that she might beneﬁt from a frontal polar resection. Most felt
that an invasive investigation to further clarify the site of onset of her
seizures would be required. Competing factors included the nature ofher warning, which might suggest early temporal involvement, and the
nature of her behavior which appeared much more frontopolar. Of note,
her EEG changes appeared to bemaximal in the F4 and FP2 electrode po-
sitions early in the events. The question of progression of her underlying
lesion as evidenced by serial MRI quantitative volumetric analysis raised
the possibility of a low-grade adult-onset chronic focal Rasmussen's en-
cephalitis. This variant of Rasmussen's encephalitis has rarely been re-
ported in adults and has been treated with variable success using
immunomodulatory drugs and focal corticectomy. Given the uncertainty
in the diagnosis, the end consensus was to biopsy one of her right frontal
lesions. Eventually, the patient underwent right frontopolar corticectomy.
The histopathology was quite unexpected. There were focal
ulegyria, cavitary gliosis sparing the molecular layer of the cortex,
and multiple foci of inﬂammatory cells, mainly T cells. There were
no microglial nodules, but there was generalized microglial activa-
tion and, probably, proliferation. There was some perivascular
cufﬁng. An HSV1 immunostain was negative. Overall, the histopa-
thology was suggestive of perinatal ischemia and a prominent in-
ﬂammatory response (Fig. 3). There was no consensus reached on
the diagnosis of Rasmussen's encephalitis.
At the last follow-up, she continued to have seizures, albeit at
a reduced frequency. Additional investigations including CSF ex-
amination, serum inﬂammatorymarkers (C-reactive protein, erythrocyte
sedimentation rate), and antinuclear antibody (ANA) screen have been
normal. The future plans are to repeat her brain MRI, with special atten-
tion to the cerebral volumes, and to reassess whether additional epilepsy
surgery or an immunomodulatory therapy would be worthwhile.3. Discussion
Acute symptomatic seizures are common after perinatal arterial
ischemic stroke, but recurrent seizures (i.e., epilepsy) have been reported
to develop in up to 67% [8,9] of patients. Incidence rates are variable and
depend on the population studied, the follow-upperiod, and the extent of
stroke. Regardless of the discrepancies between studies, it is clear that the
risk of childhood epilepsy after neonatal stroke is higher with larger
strokes [10]. Larger stroke also leads to long-term neurological disability,
including congenital hemiplegia (hemiplegic cerebral palsy) and cogni-
tive disorders. Term or near-term infants without any focal neurological
deﬁcits can have “silent” perinatal stroke. In an autopsy series of 592 in-
fants, 5.4%were found to have perinatal arterial stroke, and none showed
focal neurologic features during the newborn period [11]. Our patient had
no identiﬁable risk factors for cortical insult or any focal neurological def-
icits that should have raised the suspicion of perinatal stroke. The right
frontal encephalomalacia seen in the MRI is a nonspeciﬁc ﬁnding. Her
ﬁrst seizure occurred in adulthood, and, within a span of four years
after onset, the epilepsy worsened as evident by progressive cortical at-
rophy and increased seizure frequency. This rapid progression is atypi-
cal, considering that perinatal strokes are “static” lesions. So why is
there a progressive cortical atrophy? There was marked inﬂammation
noted in the histopathology. Is this a consequence of repeated seizures,
or is the inﬂammation contributing to the progression of the epilepsy
and atrophy? Finally, biopsy was done from one of the two noncontigu-
ous adjacent lesions. Could this be a dual pathology consisting of perina-
tal stroke and a focal, adult variant of Rasmussen's encephalitis?
Extensive inﬂammation, namely, T cells and microglial activation,
were evident in histopathology. Experimental and clinical studies have
demonstrated the role of neuroinﬂammation in establishing and main-
taining seizures in focal epilepsy [12,13]. Inﬂammation contributes to
neuronal hyperexcitability and network plasticity, can initiate seizures,
and contributes to the progression of epilepsy [14]. Inﬂammation can
also be triggered by seizures [15]. In this patient, the frequency and
the temporal relation of seizures before biopsy were not documented;
hence, it is difﬁcult to infer whether the inﬂammation is the cause or
effect following seizures. Nevertheless, inﬂammation as a contributory
Fig. 2. Volumetric analysis of serial brain MRI showing frontal lobe asymmetry (right worse than left).
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remains an attractive plausible hypothesis.
Rasmussen's encephalitis is a rare but severe inﬂammatory brain dis-
order leading to unilateral hemispheric atrophy, associated progressive
neurological dysfunction, and intractable seizures [16]. Even though
Rasmussen's encephalitis has largely been considered a childhood dis-
ease, adolescent and adult patients have been reported by several
groups [17–19]. Adults appear to have a more protracted and milder
clinical course with less residual functional deﬁcits and lower degrees
of hemiatrophy but identical histopathological as well as clinical, elec-
trophysiological, and neuroimaging ﬁndings [20]. Our patient has not
developed epilepsia partialis continua, and there was no cortical deﬁcit.
Histopathology showed T-cell-dominated inﬂammation with activated
microglia, but there were no nodules which are typically seen in
Rasmussen's encephalitis [21]. Together with the MRI ﬁndings of slow
progressive cortical atrophy, the case at least fulﬁlls the proposed
diagnostic criteria for Rasmussen's encephalitis [22] (Table 1, criteria
b). Therefore, it is possible that we are dealing with a dual pathology:
perinatal stroke and Rasmussen's encephalitis. The coexistence of
Rasmussen's encephalitis with stroke has been reported [23]. In a series
reported fromMontreal, 10% of Rasmussen's encephalitiswas associated
with dual pathology including low-grade tumor, stroke, and cortical
dysplasia [23].
How should we treat this patient? Antiinﬂammatory and immu-
nomodulatory treatments have largely been unsuccessful in most
published studies [24]. Epilepsy surgery, namely, corticectomy or
electrophysiology-guided extended lesionectomy in adult-variant
Rasmussen's encephalitis, has been reported with variable success
[20]. The case underscores the importance of considering dual
pathology in progressive disease.References
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Fig. 3. Right frontal biopsy showing focal cavitary gliosis sparing themolecular layer of the cortex (a) and ulegyria (b) in H&E staining; inﬂammatory cells CD-3/T-cells (c), CD-68/microglia (d),
and CD-20/B-cells (e).
Table 1
Diagnostic criteria of Rasmussen's encephalitis.
Adapted from Bien et al. [22]).
Part A
1. Clinical — focal seizures (with or without epilepsia partialis continua) and unilateral cortical deﬁcit(s)
2. EEG — unihemispheric slowing with or without epileptiform activity and unilateral seizure onset
3. Brain MRI — unihemispheric focal cortical atrophy and at least one of the following:
Gray or white matter T2/FLAIR hyperintense signal
Hyperintense signal or atrophy of the ipsilateral caudate head
Part B
1. Clinical — epilepsia partialis continua or progressive unilateral cortical deﬁcit(s)
2. MRI — two sequential MRIs showing progressive unihemispheric focal cortical atrophy
3. Histopathology — T-cell-dominated encephalitis with activated microglial cells (typically, but not necessarily, forming nodules) and reactive astrogliosis
RE can be diagnosed if either all three criteria of Part A or two out of three criteria of Part B are present.
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